Recurrent pregnancy loss is an important reproductive health issue, affecting 2%–5% of
couples. Common established causes include uterine anomalies, antiphospholipid …

Background The rationale behind this update of the 2016 British Society for Rheumatology
(BSR) guidelines on prescribing anti-rheumatic drugs in pregnancy and breastfeeding [1, 2] …

This evidence‐and consensus‐based guideline on the treatment of psoriasis vulgaris was
developed following the EuroGuiDerm Guideline and Consensus Statement Development …

A European League Against Rheumatism (EULAR) task force was established to define
points to consider on use of antirheumatic drugs before pregnancy, and during pregnancy …

This evidence‐and consensus‐based guideline on the treatment of psoriasis vulgaris was
developed following the EuroGuiDerm Guideline and Consensus Statement Development …

Recent Advances in Treatment of Recurrent Spontaneous Aborti... : Obstetrical & Gynecological
Survey Recent Advances in Treatment of Recurrent Spontaneous Abortion : Obstetrical & …

Objective Anti–tumor necrosis factor (anti‐TNF) medications are effective in controlling
chronic inflammatory diseases, but information about their use and safety in pregnancy is …

To describe and analyze the benefit of immunomodulatory drugs for recurrent miscarriages
and implantation failures. The literature research was conducted in Medline, Embase and …

Introduction Tofacitinib is an oral Janus kinase inhibitor for the treatment of rheumatoid
arthritis (RA), and is being investigated for the treatment of psoriasis. Both conditions can …

Women affected by autoimmune diseases, organ transplantation, or neoplasia need to
continue immunosuppressive treatment during pregnancy. In this setting, not only a careful …